Results 121 to 130 of about 5,456,142 (288)

Impact of smoking and physical activity on cardiovascular outcomes in type 2 diabetes across steatotic liver disease categories

Scientific Reports
This study investigated the effect of smoking and regular physical activity (PA) on the composite risk of cardiovascular disease (CVD) in patients with type 2 diabetes mellitus (T2DM) across different steatotic liver disease (SLD) categories. We analyzed
So Hyun Cho, Gyuri Kim, Kyu-na Lee, Rosa Oh, Ji Yoon Kim, Myunghwa Jang, You-Bin Lee, Sang-Man Jin, Kyu Yeon Hur, Kyungdo Han, Jae Hyeon Kim   +10 more
doaj   +1 more source

Metabolic Dysfunction-Associated Steatotic Liver Disease in Japan: Prevalence Trends and Clinical Background in the 10 Years before the Coronavirus Disease 2019 Pandemic

Medicina
Background and Objectives: The trends in metabolic dysfunction-associated steatotic liver disease (MASLD) and related metabolic dysfunctions in Japan are unknown.
Akira Sato, Yumiko Oomori, Rika Nakano, Tomokazu Matsuura   +3 more
doaj   +1 more source

Survival after liver transplantation in the United Kingdom and Ireland compared with the United States

, 2007
<b>Background and Aim</b>: Surgical mortality in the US is widely perceived to be superior to that in the UK. However, previous comparisons of surgical outcome in the two countries have often failed to take sufficient account of case-mix or ...
van der Meulen, JHP, Copley, LP, van der Meulen, J., Gimson, AE, Lewsey, J.D., Dawwas, M.F., Gimson, A.E., Lewsey, JD, Copley, L.P., Dawwas, MF   +9 more
core   +1 more source

Metabolic Dysfunction‐Associated Steatotic Liver Disease and Obesity: Pathogenesis, Diagnostics, Risk Stratification, and Therapeutic Approach

The Kaohsiung Journal of Medical Sciences, EarlyView.
ABSTRACT Metabolic dysfunction‐associated steatotic liver disease (MASLD) has emerged as the most prevalent chronic liver disease worldwide, closely linked to the global rising incidence of obesity and metabolic syndrome. This review synthesizes current evidence on the pathogenesis, gut–liver axis, and multidisciplinary management of MASLD within the ...
Beom Kyung Kim
wiley   +1 more source

The association between alcohol consumption and cardiometabolic factors and liver fibrosis in metabolic dysfunction-associated steatotic liver disease and metabolic dysfunction and alcohol-associated liver disease [PDF]

Background: The relationships between alcohol consumption, cardiometabolic factors, and liver fibrosis in patients with metabolic dysfunction-associated steatotic liver disease and those with metabolic dysfunction and alcohol-associated liver disease ...
60933356, 709, Kashihara, Takanori, 346380/profile-ja.html, 曽我部, 正弘, Yokoyama, Reiko, キダ, ヨシフミ, 60304515, 樫原, 孝典, 影本, 開三, 1412, 677, 364663/profile-ja.html, 佐藤, 康史, Kida, Yoshifumi, Kawano, Yutaka, 川口, 智之, 高山, 哲治, カワグチ, トモユキ, サトウ, ヤスシ, 岡久, 稔也, Miyake, Takanori, Okada, Yasuyuki, 371786/profile-ja.html, 80747650, 287, 1301, 1300, 384998/profile-ja.html, Sogabe, Masahiro, 321662/profile-ja.html, 20556807, 395217/profile-ja.html, 10284994, オカダ, ヤスユキ, タカヤマ, テツジ, Kagawa, Miwako, Tomonari, Tetsu, Takayama, Tetsuji, ソガベ, マサヒロ, トモナリ, テツ, 274188/profile-ja.html, カゲモト, カイゾウ, Kawaguchi, Tomoyuki, 1555, Okahisa, Toshiya, 1476, 852, 60732790, 友成, 哲, Kagemoto, Kaizo, 936, カシハラ, タカノリ, 169695/profile-ja.html, Sato, Yasushi, Nakasono, Masahiko, 岡田, 泰行, 80398320, 喜田, 慶史, カワノ, ユタカ, 60090/profile-ja.html, 1172, Shinomiya, Ryo, 河野, 豊, オカヒサ, トシヤ   +64 more
core  

Estimated Body Fat Percentage and Triglyceride‐Glucose Index for Identifying MASLD in Lean Asian Adults: A Cross‐Sectional Analysis

The Kaohsiung Journal of Medical Sciences, EarlyView.
ABSTRACT Metabolic dysfunction‐associated steatotic liver disease (MASLD) is increasingly prevalent among lean Asian populations, yet effective strategies for identifying high‐risk individuals remain limited. We investigated the associations of body fat percentage (BF%) and the triglyceride‐glucose (TyG) index with lean MASLD and evaluated their ...
Xiang‐Ran Kong, Ya‐Li Chen, Rui Li, Lu‐Xiang Shang, Sha Sha   +4 more
wiley   +1 more source

Steatotic liver disease, MASLD and risk of chronic kidney disease

Diabetes & Metabolism
With the rising tide of fatty liver disease related to metabolic dysfunction worldwide, the association of this common liver disease with chronic kidney disease (CKD) has become increasingly evident. In 2020, the more inclusive term metabolic dysfunction-associated fatty liver disease (MAFLD) was proposed to replace the old term non-alcoholic fatty ...
Bilson, Josh, Mantovani, Alessandro, Byrne, Christopher D, Targher, Giovanni   +3 more
openaire   +2 more sources

Epidemiology of metabolic dysfunction-associated steatotic liver disease [PDF]

As the rates of obesity and type 2 diabetes (T2D) continue to increase globally, so does the prevalence of metabolic dysfunction–associated steatotic liver disease (MASLD). Currently, 38% of all adults and 7–14% of children and adolescents have MASLD. By
Markos Kalligeros, Linda Henry, Zobair M. Younossi   +2 more
core   +2 more sources

Interactive Roles of Metabolic Dysfunction‐Associated Steatotic Liver Disease and Nutritional Status in the Prognosis of Patients With Hepatocellular Carcinoma After Surgical Resection

The Kaohsiung Journal of Medical Sciences, EarlyView.
ABSTRACT The prognostic effect of concurrent metabolic dysfunction‐associated steatotic liver disease (MASLD) on outcomes for hepatocellular carcinoma (HCC) patients remains unclear. The Prognostic Nutritional Index (PNI) reflects nutritional and inflammatory status and is a well‐known prognostic factor.
Chun‐Ting Ho, Chien‐An Liu, Chia‐Jung Ho, Yi‐Chen Lin, Shin‐Yu Tsai, Hao‐Jan Lei, Shu‐Cheng Chou, Yi‐Hsiang Huang, Ming‐Chih Hou, Jaw‐Ching Wu, Chien‐Wei Su   +10 more
wiley   +1 more source

Prevalence of metabolic dysfunction-associated steatotic liver disease in inflammatory bowel disease patients: an Egyptian cross-sectional study

The Egyptian Journal of Internal Medicine
Background Metabolic dysfunction-associated steatotic liver disease (MASLD) is increasingly recognized as a global health concern, with projections indicating it may become the leading cause of liver transplantation.
Shimaa Y. kamel, Mohamed Amin Sakr, Waleed Hamed, Hoda M. Farid, Amr Alaa El-Din, Ismail Anwar, Hany Shehab, Salma Omran, Mirella Sherif, Mohamed Negm, Nouran M. Bahig Elmihi, Dina Fathy   +11 more
doaj   +1 more source